Studies of Cardiotonic Agents. 8. Synthesis and Biological Activities of Optically Active 6-(4-(Benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl- 3(2H)-pyridazinone (KF15232)
Authors:
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (1) , 297-303
Abstract
We previously reported that (±)-6-(4-(benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone ((±)-1, KF15232) showed potent cardiotonic activity with a strong myofibrillar Ca2+-sensitizing effect. As an extension of our work, we attempted to synthesize optically active 1. (±)-4-(4-(Benzylamino)-7-quinazolinyl)-3-methyl-4-oxobutyric acid (−)-menthyl ester (6) was separated into both diastereoisomers, and each was converted to optically pure 1 (>99% ee) in an enantioselective manner. In order to determine the absolute configuration of the isomers, an alternative synthesis of optically active 1 was employed. The precursor of (−)-1 ((+)-9) was obtained by enantioselective synthesis from (R)-d-alanine. Consequently, we concluded that the absolute configuration of (−)-1 at the 5-position of the pyridazinone ring was R. The cardiotonic effects and inhibitory activities to PDE III and V of racemic 1 and (−)-1 were more potent than those of (+)-1. These compounds also demonstrated greater vasorelaxant effects in guinea pig aorta. In contrast, (+)-1 showed only weak cardiotonic and vasodilating effects, although the compound displayed potent Ca2+-sensitizing activity. Racemic and (−)-1 attracted our interest for the treatment of congestive heart failure.Keywords
This publication has 8 references indexed in Scilit:
- An enantioselective synthesis of SK&F 93505, a key intermediate for preparing cardiotonic agentsThe Journal of Organic Chemistry, 1991
- Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.Journal of Clinical Investigation, 1990
- Subclasses of cyclic AMP phosphodiesterase in cardiac muscleJournal of Molecular and Cellular Cardiology, 1987
- Inactivation of .gamma.-aminobutyric acid aminotransferase by (S,E)-4-amino-5-fluoropent-2-enoic acid and effect on the enzyme of (E)-3-(1-aminocyclopropyl)-2-propenoic acidJournal of Medicinal Chemistry, 1986
- Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failureJournal of Medicinal Chemistry, 1984
- Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failureThe American Journal of Medicine, 1980
- 6-(Substituted phenyl)-5-substituted-4,5-dihydro-3(2H)-pyridazinones. Antihypertensive agentsJournal of Medicinal Chemistry, 1974
- A General Micromethod for the Stepwise Degradation of PeptidesJournal of the American Chemical Society, 1954